$15.96
0.694.52%
Last update: Nov 9, 4:00 PM
Attovia Therapeutics Inc (ATTO) Stock Price, Quote, News & History
ATTONASDAQ
You can purchase shares of Attovia Therapeutics (NASDAQ:ATTO) through any online brokerage.
Other companies in Attovia Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Attovia Therapeutics has a consensus price target of $42.20.
The stock price for Attovia Therapeutics (NASDAQ: ATTO) is $15.96 last updated November 9, 2026 at 4:00 PM EST.
There are no upcoming dividends for Attovia Therapeutics.
Attovia Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Attovia Therapeutics.
Attovia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology...
